Redsense Medical AB (publ) (NGM: REDS)

Market Cap	113.47M
Revenue (ttm)	24.49M
Net Income (ttm)	-3.98M
Shares Out	16.44M
EPS (ttm)	-0.27
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	792
Open	n/a
Previous Close	n/a
Day's Range	n/a
52-Week Range	4.51 - 11.20
Beta	0.49
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 8, 2024

About Redsense Medical AB

Redsense Medical AB (publ) develops, markets, and sells monitoring systems for medical treatments primarily in Europe and the United States. The company offers Redsense System, a medical technology product that is used for monitoring and alarming in the event of blood leakage in connection with a hemodialysis treatment. It also provides Redsense Clamp, which clamps the bloodline to stop blood flow when the alarm unit detects a blood leakage. The company serves the requirements of healthcare providers in the dialysis sector. Redsense Medical AB ...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2000
• Employees: 5
• Stock Exchange: Nordic Growth Market
• Ticker Symbol: REDS

Financial Performance

In 2023, Redsense Medical AB's revenue was 25.52 million, an increase of 52.32% compared to the previous year's 16.75 million. Losses were -4.51 million, -48.47% less than in 2022.